Cargando…

Pseudoprogression in low-grade glioma

Detalles Bibliográficos
Autores principales:	Slater, Jason M., Shih, Helen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798295/ https://www.ncbi.nlm.nih.gov/pubmed/35117135 http://dx.doi.org/10.21037/tcr.2019.11.16

Ejemplares similares

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma()
por: Bronk, Julianna K., et al.
Publicado: (2018)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
por: YOO, Roh-EUL, et al.
Publicado: (2015)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Tackling Pediatric Low-Grade Gliomas: A Global Perspective
por: Moreira, Daniel C., et al.
Publicado: (2023)

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
por: Abbasi, Abdul W., et al.
Publicado: (2017)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis
por: Taylor, Chris, et al.
Publicado: (2022)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Pseudoprogression prediction in high grade primary CNS tumors by use of radiomics
por: Ari, Asena Petek, et al.
Publicado: (2022)

Much debated controversies of diffuse low-grade gliomas
por: Zadeh, Gelareh, et al.
Publicado: (2015)

The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis
por: Zhou, Min, et al.
Publicado: (2019)

Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group
por: Chang, Ji Hyun, et al.
Publicado: (2014)

Multiple synchronous gliomas of distinctly different grades
por: Kelly, Patrick J.
Publicado: (2010)

(11)C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas
por: Hatazawa, Jun
Publicado: (2018)

Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
por: Marosi, Christine
Publicado: (2018)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
por: Zikou, Anastasia, et al.
Publicado: (2018)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

A case report of pseudoprogression followed by complete remission after proton-beam irradiation for a low-grade glioma in a teenager: the value of dynamic contrast-enhanced MRI
por: Meyzer, Candice, et al.
Publicado: (2010)

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
por: Lanese, Andrea, et al.
Publicado: (2018)

High-grade gliomas: reality and hopes
por: Mirimanoff, René-Olivier
Publicado: (2014)

The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis
por: Wan, Bing, et al.
Publicado: (2017)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma
por: Kebir, Sied, et al.
Publicado: (2016)

Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review
por: Raza, Istafa J., et al.
Publicado: (2020)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes
por: Richter, Vivien, et al.
Publicado: (2021)

Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
por: Jones, Tiffany Nicole, et al.
Publicado: (2023)

Management of Low-Grade Glioma
por: Pouratian, Nader, et al.
Publicado: (2010)

Pediatric Low-Grade Gliomas
por: Collins, Kelly L., et al.
Publicado: (2020)

The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas
por: Jing, Hui, et al.
Publicado: (2022)

Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis
por: Ouyang, Zhi-Qiang, et al.
Publicado: (2023)

RARE-15. EARLY PSEUDOPROGRESSION POST-RADIATION IN PAEDIATRIC HIGH-GRADE GLIOMA PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY: TWO CASE REPORTS FROM A SINGLE CENTRE
por: Teng, Ay-Jiuan, et al.
Publicado: (2020)

STINGing the immune system: lessons learned through a model of G34-mutant pediatric high-grade glioma
por: Hall, Connor P., et al.
Publicado: (2022)

Delayed pseudoprogression of a vestibular schwannoma postradiosurgery
por: Malone, Janna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ghr3o05og4v0iov5vnjuilg7c0